Video • Handheld rapid testing

New tech to diagnose infections in minutes - without a lab

The idea of visiting the doctor’s office with symptoms of an illness and leaving with a scientifically confirmed diagnosis is much closer to reality because of new technology developed by researchers at McMaster University.

Engineering, biochemistry and medical researchers from across campus have combined their skills to create a hand-held rapid test for bacterial infections that can produce accurate, reliable results in less than an hour, eliminating the need to send samples to a lab. Their proof-of-concept research, published in the journal Nature Chemistry, specifically describes the test’s effectiveness in diagnosing urinary tract infections from real clinical samples. The researchers are adapting the test to detect other forms of bacteria and for the rapid diagnosis of viruses, including Covid-19. They also plan to test its viability for detecting markers of cancer.

Photo
Source: McMaster University

“It’s going to mean that patients can get better treatment, faster results and avoid serious complications. It can also avoid the unnecessary use of antibiotics, which is something that can buy us time in the battle against antimicrobial resistance,” says Leyla Soleymani, the paper’s co-corresponding author and an associate professor of engineering physics. “This will give doctors the science to support what they already suspect based on their skills and experience,” says co-corresponding author Yingfu Li, a professor of biochemistry and biomedical sciences.

The new DNA-based technology uses a handheld device similar to a blood-glucose monitor. A microchip analyzes a droplet of bodily fluid such as blood, urine or saliva, using molecules that can detect the specific protein signature of an infection. The device, about the size of a USB stick, plugs into a smartphone, which displays the result. The invention combines electrochemical engineering technology developed by Soleymani and her team with biochemical technology developed by Li and his colleague Dingran Chang. They worked with infectious disease clinician Marek Smeija, a professor of medicine who provided samples from real patients, and with Todd Hoare, a professor of chemical engineering. “As scientists, we want to enable things,” says Li, “We are knowledgeable in different scientific and engineering principles, and when you put them together to help people, that’s a special feeling. Having the chance to impact society is the reason we all do this work.”

This technology is very versatile and we’re getting very close to using the same technology for Covid-19 testing

Yingfu Li

Existing practice typically requires sending samples to laboratories to be cultured, a process that can take days. Providing immediate results to patients can reduce the spread of infection, improve patients’ quality of life and simplify the work of busy clinicians. The new technology can distinguish strains of the same bacteria that can be treated with antibiotics from others that are resistant to antibiotics, a critical distinction that can help battle the growing problem of antimicrobial resistance, or AMR. “Clinicians identified testing delays as a problem that needed to be resolved,” says Soleymani, who holds the Canada Research Chair in Miniaturized Biomedical Devices. “We wanted to build a system that could give as much information as possible to the physician during the patient’s first visit.”

The researchers are in the midst of testing an adaptation of the same technology for the virus that causes Covid-19, using samples from a Hamilton clinic. “This technology is very versatile and we’re getting very close to using the same technology for Covid-19 testing,” says Li, who is also a member of McMaster’s Michael Groote Institute for Infectious Disease Research. The researchers are exploring regulatory approvals and industry partnerships to get the technology into wide use as quickly as possible, not only in Canada, but around the world, especially where access to lab testing is limited or non-existent. “I think this technology is a step toward democratizing disease diagnosis and management,” says lead author Richa Pandey, a post-doctoral research fellow in Soleymani’s lab. “This is technology that can go anywhere in the world where testing is needed.”


Source: McMaster University (CC BY-ND 3.0)

25.06.2021

Read all latest stories

Related articles

Photo

News • Deep mutational scanning for SARS-CoV-2

Preparing rapid tests for future coronavirus variants

How can rapid antigen tests be adjusted to reliably detect future variants of SARS-CoV-2? A research team funded by the National Institutes of Health is currently working on finding an answer.

Photo

News • Coronavirus mechanism discovered

Organ-on-a-chip reveals how SARS-CoV-2 invades blood vessels

A research group has revealed that SARS-CoV-2 disrupts the vascular endothelial barrier by suppressing the expression of Claudin-5 (CLDN5) to invade the blood vessels.

Photo

Article • Modelling systems for human biology

Organoid technology: new opportunities for drug discovery

Two-dimensional (2D) cultured cell lines and animal models have been the principal research tools for the past decade, but have several shortcomings. Three-dimensional cell cultures, or organoids,…

Related products

Beckman Coulter – DxA 5000

Automation

Beckman Coulter – DxA 5000

Beckman Coulter Diagnostics
Mindray - CL-8000i Chemiluminescence Immunoassay System

Immunoassays

Mindray - CL-8000i Chemiluminescence Immunoassay System

Shenzhen Mindray Bio-Medical Electronics Co., Ltd
Siemens Healthineers – Aptio Automation

Automation

Siemens Healthineers – Aptio Automation

Siemens Healthineers
ASP Lab Automation – SortPro Sample sorter

Sample Processing

ASP Lab Automation – SortPro Sample sorter

ASP Lab Automation AG
Beckman Coulter – Access 2 Immunoassay System

Immunoassays

Beckman Coulter – Access 2 Immunoassay System

Beckman Coulter Diagnostics
Subscribe to Newsletter